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The question whether symptom-free migraine patients show cognitive impairments compared to matched 
control subjects is addressed, and also whether migraine patients show transient cognitive impairments 
induced by an attack. The Neuropsychological Evaluation System (NES2) was administered once in an 
interictal period and twice within 30 h after different migraine attacks. Since cognitive impairments could 
be related to attack duration or severity, cognitive performance was compared during a postictal period 
after sumatriptan use and during a postictal period after habitual nonvasoactive medication use. Twenty 
migraineurs without aura, 10 migraineurs with aura, and 30 matched headache-free controls participated in 
the study. During a headache-free period, migraineurs without aura responded as quickly as controls, 
while migraineurs with aura were slower than controls during all tasks specifically requiring selective 
attention. These effects were not aggravated by a preceding migraine attack, irrespective of medication use 
and attack duration. q Cognitive functioning, interictal, migraine, postictal, sumatriptan 
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studies have provided evi- 
deficits in migraine patients, 
control. These results, along with limited food 
tolerance, tiredness, altered mood state, and diur- 
including psychomotor deficiencies (1, 2), memory 
deficits (2,3), and dysfunctions in the early stages of 
visual processing (4, 5), especially in migraineurs 
with aura (3, 6, 7). However, in other studies, 
neither detrimental cognitive effects in migraine 
patients nor differences between migraineurs with 
and without aura have been found (8, 9). Factors 
that could contribute to these inconsistent results 
are patient selection biases, a lack of distinction 
between migraineurs with aura and migraineurs 
without aura, the absence of matched control 
groups, and the presence of type I errors as a 
result of multiple testing without adjustment of the 
nominal alpha level. The time interval between a 
migraine attack and task performance can also be 
an important factor. 
Inter&al brain functioning can be influenced by 
functional or structural effects of migraine on the 
one hand, and temporal and reversible effects of an 
attack on the other. Cognitive performance can be 
temporarily adversely affected by the physiological 
dynamics of a preceding or upcoming migraine 
attack. Post-attack effects can be pronounced, since 
a migraine ‘headache is followed by transient 
physiological alterations remaining for up to 48 h 
after an attack, e.g., regional cerebral blood flow 
abnormalities (lo), a reduction of alpha activity 
within the background EEG (11), and a reduction of 
the Contingent Negative Variation amplitude 
(12+an event-related cortical potential reflecting 
noradrenergic arousal and dopaminergic motor 
esis (13), suggest a physiological recovery phase 
which could also lead to an impaired cognitive 
performance in the post-attack period. 
The present study addresses two main questions: 
the first whether migraine patients show cognitive 
impairments in an interictal period compared to 
matched headache-free control subjects; the second 
whether migraine patients show transient cognitive 
impairments during the post-attack period, and 
whether these impairments are related to the 
duration or the severity of the preceding attack. 
Cognitive performance was therefore compared 
during a post-attack period after sumatriptan use 
and during a post-attack period after habitual 
nonvasoactive medication use, such as aspirin or 
analgesics. Sumatriptan is a selective vascular 5IIT1 
receptor agonist and is more effective than a 
placebo or aspirin in combination with metoclopra- 
mide in the relief of migraine headache (14). 
Methods 
Subjects 
Thirty migraine patients (20 without aura, 10 with 
aura) and 30 matched healthy controls participated 
in the study. All were students and were recruited 
by advertisements in university papers. Patients 
were diagnosed by a neurologist in accordance with 
the International Headache Society (IHS) criteria for 
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migraine (15) before being physically examined, they were matching. Furthermore, the intervals 
interviewed, and included in the study. Migraine between the control sessions were equivalent to 
patients using prophylactic medication, monoamine the test intervals of the patient they were matching. 
oxidase inhibitors, beta blockers, serotonin re- 
uptake inhibitors, or lithium, and-patients with a 
known hypersensitivity, intolerance, or contraindi- 
cation to the use of sumatriptan were excluded from 
the study. All patients had used sumatriptan at least 
once before participation in the laboratory sessions. 
Control subjects were selected from the same 
student population and matched to every migraine 
patient on the basis of gender, age, and handedness. 
Socioeconomic status was comparable between 
patients and control subjects. Controls neither 
suffered from migraine nor any other type of 
headache more than once per 2 months (e.g., due 
to alcohol consumption or exposure to toxic 
substances). Subjects were not admitted to the 
study if they had a history of epilepsy, possible 
risk of structural brain lesions, other severe medical 
conditions which could affect the interpretation of 
the results, current abuse of opiate- analgesics, 
psychotropic drugs, ergotamine (> 10 mg/week) 
or alcohol (>315 g/week), or a history of abuse 
of these substances in the previous 6 months. 
l3esig-n 
Neuropsychological data were obtained during 
three sessions in patients and controls. Patients 
were tested following three different attacks. The 
first session took place on a headache and 
symptom-free day, at the 4th or 5th day following 
the peak of a migraine attack. If the first session was 
followed by a new migraine attack within 3 days, 
this session was considered invalid. The 2nd and 
3rd sessions took place within 30 h after a migraine 
attack, but after one proper night’s rest, when the 
headache severity had declined to, at most, mild, as 
judged on a three-point scale (1 = mild, 2 = moder- 
ate, 3 = severe). During the attack directly preceding 
one postictal session, patients used their habitual 
migraine medication, which could also be no 
medication. During the attack preceding the other 
postictal session, the migraine patients used 100 mg 
sumatriptan tablets. The order of habitual medica- 
tion and sumatriptan use was counterbalanced over 
the 2nd and 3rd attacks. 
Mediated by test habituation and learning, 
repeated testing in itself will give rise to session 
effects. The repeated testing of the control subjects 
is necessary to identify postictal effects in migrai- 
neurs. because it will be confounded with the 
All subjects abstained from alcohol, tobacco, and 
caffeine during the hours prior to testing as well as 
during the testing procedure. Each session began 
with completion of a Visual Analogue Scale (VAS) 
to determine the headache severity of the preceding 
migraine attack. The extremes of pain were “no 
pain” and “as bad as it could be”, and migraineurs 
marked the degree of pain on the line representing 
a 0- 100 scale. Additionally, patients reported the 
current subjective impairment by answering the 
following question with yes or no: “Do you feel that 
you are still impaired by your last migraine attack 
at the moment (in the sense that you feel impaired 
in your ability to concentrate, in your alertness, 
clear-headedness, or to execute your daily activ- 
ities)?” Furthermore, at the beginning of each 
session the number of hours that had passed 
since meaningful relief from the migraine headache 
was determined, as well as since medication intake, 
based on the diaries that were kept during the 
attack. Duration of the preceding migraine attack 
was determined by a single question: “How many 
hours did your migraine attack last?” Subjects were 
seated behind a table in a dimly lit and quiet room, 
facing a computer. A keyboard and joystick served 
as response devices. Subjects were instructed to 
work as quickly but as accurately as possible. The 
total administration time of the NES2 was about 75 
min. 
sess& effects. Control subjects were tested while 
headache-free and without having used medication 
Data reduction and analyses 
during the same period of the week (beginning, The SUMM program of the NES2 was used for a 
middle, weekend) and at the same time during the first level of data reduction. The dependent vari- 
day (morning, afternoon, evening) as the patient ables computed by this program mainly reflect 
Neuropsychological testing 
Neuropsychological testing was done with the 
second version of the Neurobehavioural Evaluation 
System (NES2) (16). The NES2 has been shown to be 
a sensitive instrument for the detection of afflictions 
of the central nervous system (17). It is a self- 
administered test during which the subject is 
required to go through all the tests guided by the 
instructions given on the computer screen at the 
beginning of each task. The test battery involves 
three broad functional domains: cognitive, memory 
and learning, and psychomotor functions. Emmen 
et al. (18) translated and adapted the NES2 for 
administration in The Netherlands. The individual 
tasks are briefly described in Appendix 1. 
Procedure 
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processing speed in the cognitive, memory and 
learning, and psychomotor domain. To obtain an 
empirical and finer level of clustering of the 
neuropsychological data, Principal Component 
Analysis (PCA) was used to cluster all variables 
reflecting processing speed in the baseline session 
from all patients and controls, after subtracting the 
group means and removing outliers from every 
task. After VARIMAX rotation, seven components 
were obtained explaining 73% of the variance and 
denoting the following domains: reasoning, reaction 
speed, motor functioning, selective attention, digit 
encoding, visual digit span, and pattern perception 
(see Appendix 1). In addition to processing speed, 
accuracy measures (e.g., the number of false- 
positives and false-negatives during a task) were 
available in some subtasks (see Appendix 1). The 
distributions of these individual accuracy scores 
were either extremely asymmetrical or showed very 
little variability. Therefore, the individual accuracy 
scores at our disposal within each PCA cluster were 
summed, which led to five accuracy sum-scores: 
reasoning (sum of correct responses in each condi- 
tion), reaction speed (correct responses summed for 
each test in this cluster except for the simple 
reaction time task), selective attention (omissions 
and false-positive responses derived from all tasks 
within this cluster), digit encoding (correct 
responses in the horizontal addition task), and 
pattern perception (correct responses from both 
tasks in this cluster). 
Age, history, and general attack severity (see 
Table 1) were compared between migrameurs with 
aura and migraineurs without aura by submitting 
these variables to one-way ANOVAs using the 
GLM module of SPSS 7.5. These analyses included 
the between subjects factor Aura (migraineurs with 
aura, migraineurs without aura). The session 
characteristics listed in Table 1 were submitted to 
ANOVAs for repeated measures. These analyses 
included the within subjects factor Session (post- 
attack session after sumatriptan use, post-attack 
session after usual medication use), and the 
between subjects factor Aura (migraineurs with 
aura, migraineurs without aura). Processing speed 
variables and accuracy sum-scores were submitted 
to analyses for paired observations to increase 
statistical power. An individual migraine patient 
and the matched control were considered as one 
case and constitute the within subjects factor Pair 
(migraineurs, controls). The second within subjects 
factor is Session with three levels (baseline session, 
post-attack session after sumatriptan use, post- 
attack session after usual medication use). This 
implies that each case contained six observations. In 
order to group the patients in migraineurs with 
aura and migraineurs without aura, each case was 
coded by the between subjects factor Aura (migrai- 
neurs with aura, migraineurs without aura). 
First, we compared migraineurs to controls in the 
baseline session and executed ANOVAs with the 
within subjects factor Pair (migraineurs, controls) 
and the between subjects factor Aura (migraineurs 
with aura, migraineurs without aura). Second, we 
compared the baseline session to the postictal 
sessions between migraineurs and controls. For 
this purpose, we entered all sessions to ANOVAs 
for repeated measures with the within subjects 
factors Pair (migraineurs, controls) and Session 
(baseline session, post-attack session after suma- 
triptan use, post-attack session after usual medica- 
tion use), and the between subjects factor Aura 
(migraineurs with aura, migraineurs without aura). 
We hypothesize that migraine patients are slower 
and make more errors than control subjects, and 
that migraineurs with aura are slower and make 
more errors than migraineurs without aura. During 
the postictal sessions we expect that these group 
differences will be smaller after sumatriptan use 
than after usual medication intake. Therefore, these 
specific effects will be tested one-tailed. Main 
session effects will not be reported since they reflect 
learning and habituation effects of equal magnitude 
in migraineurs and controls across the sessions. 
However, if postictal effects are present in migraine 
patients, these will be reflected in significant 
Pair x Session or Pair x Session x Aura interactions. 
One-tailed follow-up tests ensued the detection of 
significant interactions. The Holm method (19) was 
used to reduce type 1 errors by ensuring that the 
family wise significance level did not exceed 
01=0.05 after multiple statistical testing within 
each cluster of variables. This method was also 
used for the follow-up tests. Univariate test results 
are reported after Huynh-Feldt s-tilde adjustment. 
Furthermore, Levene tests were executed to ensure 
that the assumption of homogeneity of variances 
between groups was met, if necessary after a 
transformation of the dependent variable. For this 
purpose, a logarithmic transformation was executed 
on the intervals between the sessions, a square root 
transformation was executed on attack duration, 
and two migraine patients were removed from and 
replaced by the group means of grammatical 
reasoning (these patients had correct response 
rates of less than 50%) and attack severity. 
Results 
Demographics and clinical session characteristics 
Table 1 depicts the demographics and clinical 
session characteristics of the migraineurs with aura 
and the migraineurs without aura. Age and years of 
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Table 1. Demographics and clinical session characteristics. 
Migraineurs 
with aura (n=lO) 
Migmineurs 
without aura (n=20) 
Female/male 8/2 18/2 
Left/right handed l/9 4/16 
Age 24.3 (4.9) 24.9 
Migrame history (years) 7.1 . (3.8) 6.2 
Subjective reporting of impairment during session (% of patients) 
sumatriptan 80 45 
Usual medication 60 55 
Interval between sessions (months) 
Baselin~umatriptan 6.4 
Baseline--usual medication 3.3 
;g; g 
. 
Hours between medication intake and start session 
sumatriptan 23.1 21.8 
Usual medication 26.5 ii’:; . 25.8 
Hours between meaningful relief and start session 
sumatriptan 17.7 16.2 
Usual medication 14.8 ;::; 12.5 
Attack duration’ (h) * 
sumatriptan 7.6 
::; 
10.7 
Usual medication 13.4 17.6 
Headache severity (VAS: 0- 100) 
Attack in general # 67 
sumatriptan 61 ;z; E 
Usual medication 64 (21) 71 
Results are given as means and (standard deviations). 
‘Attack duration is determined by the number of hours between prodromina and meaningful relief. 
‘Significant difference between sumatriptan and usual medication use (~~0.02). 
:z . 
(5.2) 
(5.4) 
(8.1) 
(13.4) 
$:$ 
(12.1) 
(13.9) 
I:$ 
(19) 
migraine history were equal between these patient 
groups. General headache severity was higher in 
migraineurs without aura than in migraineurs with 
aura [F&28) = 8.4, p < 0.021. Headache severity was 
equal during the attack when sumatriptan was used 
compared to when usual. medication was used. 
Attack duration was shortened by sumatriptan use 
compared to usual medication use [F&28) =11.3, 
p -c 0.011. Furthermore, there was no significant 
difference in the hours that had passed between 
both types of medication intake and the start of the 
following postictal sessions. Similarly, the hours 
that had passed since meaningful headache relief 
after both types of medication at the start of the 
postictal sessions were not significantly different. 
Furthermore, the session intervals of migraineurs 
with aura and migraineurs without aura were 
similar. 
Cognitive and motor speed in interictal migraineurs 
versus controls 
Table 2 depicts the group means of the speed 
measures showing significant baseline effects. 
During the baseline session, migraine patients 
(migraineurs with aura and migraineurs without 
aura) showed equal cognitive accuracy as controls 
within all domains of cognitive functioning. How- 
ever, they were slower compared to their controls 
during the pattern memory tasks within the pattern 
perception domain [F(1,28) = 5.6, p < 0.031. 
Migraine patients with aura and migraine patients 
without aura. -Within the motor function domain, 
migraineurs with aura produced fewer taps than 
control subjects with the preferred hand 
[F(1,28) = 7.8, p < 0.021, while migraineurs without 
aura were equally as fast as controls. Migraine 
patients with aura were significantly slower com- 
pared to their controls during all tests within the 
selective attention domain (continuous perfor- 
mance with pictures: [F( 1,28) = 11.4, p < 0.021, con- 
tinuous performance with letters: [F(128) = 4.7, 
p < 0.051, color word task: [F(1,28) = 1.1, p < 0.03]), 
while migraine patients without aura were equally 
as fast as controls. During the symbol digit substi- 
tution task, migraineurs with aura were slower 
than their controls [F(1,28) = 18.6, p <0.03], but 
migraine patients without aura were equally as 
fast as controls. 
Cognitive and motor speed during interictal versus 
postictal sessions 
Table 3 lists the significant effects and the group 
means of the cognitive and motor speed measures 
during the baseline, the post-attack session after 
sumatriptan use, and during the post-attack session 
after usual medication use. Cognitive speed and 
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Tabk 2. Cognitive and motor speed in interictal migraineurs versus controls. 
Motor functioning 
Finger taps preferred 
Selective attention (ms) 
CP with pictures 
CP with letters 
Color word 
Digit encodhg 
S= (m) 
Pattern perception (ms) 
Pattern memory 
Control Aura No aura 
179 (28) 166 (24) 174 (30) 
490 (55) 518 (53) 516 (54) 
390 (46) 393 (29) 390 WV 
586 (51) 617 (47) 604 (45) 
217 (23) 250 (23) 225 (28) 
428 (87) 489 (127) 462 (101) 
Data are given in means and (standard deviations) and are collected in controls (n =30), migraine patients without aura (n =20), 
and migraine patients with aura (n =lO). 
*significant difference between inter&al migrahurs and controls. 
“Significant difference between interictal mi~aineurs with aura and controls (p ~0.05, ms =milEseconds; CP=continuous 
perfohance task; SYMDG =symbol digit substit&m task). 
accuracy were not significantly affected in the 
postictal sessions in migraineurs compared to the 
baseline session, as was indicated by the absence of 
Pair x Session effects. Averaged across the sessions, 
migraine patients produced fewer taps han controls, 
using the preferred hand [F(1,28) =4.33, p < 0.031, the 
nonpreferred hand [F&28) = 13.84, p < 0.011, and 
alternating hands [F&28) = 5.0, p < 0.021. 
slower than those without aura during this task 
across all sessions [F&28) = 10.6, p <0.03], while 
migraineurs without aura were equally as fast as 
control subjects. During the pattern perception 
tasks averaged over all sessions, migraineurs with 
aura had two errors more than controls 
[F(1,28) =4.1, p <0.05]. These findings were 
obtained by follow-up testing of significant Pair x 
Aura effects. 
Migraine patients with aura and migraine patients Compared to their controls, the differences 
without aura. -When averaged over the three ses- between migraine patients with aura and migraine 
sions, migraineurs with aura were slower than patients without aura were equal in each of the 
their control subjects during all tests of the selec- three sessions, which was indicated by the absence 
tive attention domain (continuous performance of significant Pair x Session x Aura or Session x 
with pictures: [F(l,28) = 8.1, p < 0.021, continuous Aura interactions. One significant Pair xSession 
performance with letters: [F( 1,28) = 3.8, p < 0.051, interaction was detected for the continuous perfor- 
color word task: [F(1,28) =8.3, p < 0.03]), while mance with pictures task [F(2,56) =3.35, p =0.02]. 
migraineurs without aura were equally as fast as This reflected that the prolonged reaction time 
their control subjects. Furthermore, in congruence 
with the symbol digit substitution task during the 
present at baseline in migraineurs compared to 
baseline session, migraineurs with aura were 
controls was significantly reduced during the post- 
attack sessions [F(1,29) = 8.12, p -c 0.031. In addition, 
Table 3. Cognitive and motor speed during interictal versus postictal sessions. 
hlterictal sumatr.iptan Usual medication 
Control Aura No aura Control Aura No aura Control Aura No aura 
Motor functioning 
Finger taps p&erred 0 179 (28) 166 (24) 174 (30) 185 (27) 178 (17) 178 (26) 186 (27) 172 (42) 178 (22) 
Finger taps nonpreferred 0 167 (37) 150 (26) 157 (21) 191 (37) 157 (17) 168 (24) 193 (45) 157 (31) 169 (29) 
Finger taps alternating 0 223 (49) 211 (35) 191 (26) 235 (47) 211 (20) 199 (54) 231 (47) 212 (23) 203 (32) 
Selective attention (ms) 
CP with pictures #a 490 (55) 518 (53) 516 (54) 493 (71) 490 (46) 498 (44) 491 (68) 519 (78) 500 (60) 
CP with letters # 390 (46) 393 (29) 390 (40) 394 (47) 393 (46) 391 (33) 3% (46) 395 (36) 385 (35) 
Color word # 586 (51) 617 (47) 604 (45) 579 (67) 600 (29) 592 (52) 590 (62) 603 (25) 581 (52) 
Digit encoding 
SYMDG WI # 217 (23) 250 (23) 225 (28) 202 (27) 233 (14) 209 (26) 203 (24) 230 (7) 205 (21) 
Data are given in means and (standard deviations) and are collected in controls (n = 30), migraine patients without aura (n = 20) and 
migraine patients with aura (n = 10) during an inter&al session, during a post-attack session after sumatriptan use and during a post- 
attack session after usual medication use. (0) Significant difference between migraineurs and controls across all sessions. (#) 
Significant difference between migraineurs with aura and controls across all sessions. (0) Significant Pair x Session interaction 
(pcO.05, ms =milheconds; CP=continuous performance task; SYMDG=symbol digit substitution task). 
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the prolonged reaction time of migraineurs at 
baseline was not significantly different during the 
postictal session after usual medication intake but 
was significantly smaller after sumatriptan had 
been used [F(1,29) = 8.12, p ~0.021. This Pair x Ses- 
sion interaction effect of the continuous perfor- 
mance task with pictures is depicted in Fig. 1. 
Discussion 
The first question addressed in the present study is 
whether interictal migraineurs with aura and 
migraineurs without aura showed cognitive impair- 
ments compared to matched and healthy control 
subjects. Migraine patients without aura performed 
as fast as control subjects on the cognitive tests. 
However, cognitive speed was lower in migraineurs 
with aura in several cognitive domains. Migraineurs 
with aura were slower than controls during the 
symbol digit substitution test, which invokes func- 
tions such as visual processing, encoding, short- 
term memory, and sustained attention. Since there 
were no other detrimental effects detected in 
migraineurs with aura during other tests within 
the digit encoding domain or during tests requiring 
short-term memory, the slower response during 
symbol digit substitution can be primarily 
explained by an impaired ability in visual proces- 
sing or sustained attention. Since the reaction times 
during the pattern perception tasks were equal 
between migraineurs with aura and their matched 
controls we could not confirm the presence of visual 
processing deficiencies in migraineurs with aura (7). 
From the present results, we therefore conclude that 
the slower response during symbol digit substitu- 
tion mainly reflects an impairment in sustained 
attention in migraineurs with aura. 
This finding is strengthened by the results that 
migraine patients with aura were slower than 
controls during the two continuous performance 
Baseline 
Fig. 2. Mean reaction time and standard errors of migraineurs 
(grey bars) and controls (black bars) in the continuous perfor- 
mance test with pictures at the baseline session, at the post- 
attack session after sumatriptan use and at the post-attack ses- 
sion after usual medication use. 
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tests as well as during the Stroop color word test. 
besides sustained attention, performance on these 
tests mainly indexes selective attention on a 
relevant stimulus dimension, while responses to 
irrelevant dimensions have to be inhibited. Resis- 
tance to interference and controlling interference 
from both external and internal sources also play a 
prominent role in performance on these tests. 
Although some evidence of motor slowing was 
found in migraineurs, this cannot explain the 
slowed responses during selective attention, 
because motor slowing should then have been 
detrimental to the reaction speed domain also 
where the required motor response was similar. 
Since this was not the case, we conclude that when 
the suppression of responses to nontargets is 
necessary, cognitive speed is especially impaired 
in migraineurs with aura. The orbital prefrontal 
cortex participates in controlling these selective 
aspects of attention. Dorsolateral areas of the 
prefrontal cortex are involved in sustained focusing 
attention. The anterior cingulate gyms in the medial 
prefrontal cortex is activated during concentrated 
attention such as the Stroop task (20). Our findings 
suggest that a functional disturbance may be 
present in prefrontal cerebral areas of migraineurs 
with aura. 
Cognitive impairments have been suggested as 
being predominantly present in migraine patients 
with profound neurologic complaints and in 
patients seeking medical help (8). Since migraineurs 
with neurologic symptoms such as epilepsy, hemi- 
plegia, fainting or exceptionally long and frequent 
attacks were excluded from the study, such a 
patient selection bias is unlikely to explain the 
attention deficit that was found in migraineurs with 
aura in the present study. 
Although recent neuroimaging studies question 
the presence of cerebral atrophy or neuronal 
damage in migraine patients (21), the long-term 
exposure to migraine attacks might eventually lead 
to cerebral damage (22,23). The attack duration and 
severity, the length of the migraine history and age 
are factors that have implicitly been assumed to 
influence the extent of this damage and cognitive 
dysfunctions. However, these factors cannot explain 
why, exclusively, migraineurs with aura showed 
cognitive impairments in the present study because 
(i) attack duration was equal between migraineurs 
with aura and migraineurs without aura, (ii) 
migraineurs with aura rated their general attack 
severity to be even lower than patients without 
aura, and (iii) the length of migraine history and 
age were equal between migraineurs with and 
without aura. In addition, it should be noted that 
the patients in the present study are young 
compared to other studies where similar cognitive 
impairments were found (2, 3). The present study, 
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along with other studies suggesting that cognitive 
impairment is unrelated to the length of migraine 
history (2, 3, 8), does not support the notion that 
cognitive dysfunctioning is a consequence of the 
cumulative effects of repeated migraine attacks. 
Alternatively, the impaired cognitive functioning 
in migraineurs with aura can be due to a predis- 
position to migraine with aura rather than a 
consequence of repeated attacks. What kind of 
underlying factors could predispose subjects to 
migraine with aura and could affect attention as 
well? Ophoff (24) found a genetic factor in familial 
hemiplegic migraine, expressed in a structural 
disturbance in the calcium channels of cortical 
neurons that are involved in the signal transmis- 
sion. These findings apply to hemiplegic migraine, 
but similar results may be found in other types of 
migraine as well. Ophoff (24) suggests that such a 
genetic predisposition could evoke a heightened 
susceptibility to the generation of a spreading 
cortical neuronal depression which may underlie 
the aura symptoms of migraine. Peroutka et al. (25) 
have found the frequency of the dopamine DRD2-C 
allele of the NcuI polymorphism to be selectively 
increased in migraine patients with aura. Since 
dopamine receptors play a role in cognitive 
functioning, the impaired sustained attention in 
migraineurs with aura may stem from a disturbed 
dopamine sensitivity. Another predisposing factor 
for the cognitive impairment in migraineurs with 
aura could be a hyperactive central catecholamine 
system, which has been associated with migraine 
(26). A hyperactive catecholamine system has been 
reported in migraineurs without aura and was 
found to normalize during an attack (12). If this 
system plays a role in cognitive functioning, this 
may result in an improved cognitive performance 
during the postictal period compared to the 
interictal period. However, the present study did 
not provide substantial evidence for such an 
improvement, except for the continuous perfor- 
mance task with pictures. 
The second question addressed in the present 
study was whether there are transient negative 
effects of a migraine attack on cognitive functioning. 
The majority of the migraineurs with aura subjec- 
tively reported impairments during the postictal 
period, especially after sumatriptan use. This could 
be due to side effects such as malaise, fatigue, and 
dizziness, all of which are frequently experienced 
after sumatriptan use (14). However, this subjective 
impairment was not reflected in the neuropsycho- 
logical test results. There were no aggravations 
detected in the existing interictal impairments of 
symbol digit substitution and the three tests of 
selective attention in the postictal period. In 
addition, an attack did not introduce new detri- 
mental effects, irrespective of attack duration or the 
lnterictal and postictal cognitizle changes in migraine 563 
type of medication that was used. On the contrary, 
the prolonged reaction time of the total group of 
interictal migraineurs compared to controls during 
the continuous performance test with pictures was 
reduced in the post-attack period, specifically after 
sumatriptan use. 
ln conclusion, migraineurs with aura were slower 
than controls during the symbol digit substitution 
task and during all tests specifically requiring 
selective attention. These effects were not aggra- 
vated by a preceding migraine attack irrespective of 
medication use and attack duration. In spite of 
physiological studies suggesting a migraine recov- 
ery phase up to 48 h after an attack (lo- 12), the 
present study did not support the idea that a 
migraine attack induces neuronal alterations that 
affect cognitive functioning during the postictal 
period. 
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Appendix 1. Description of NESZ tasks 
Reasoning 
Reasoning: This is a verbal grammatical reasoning 
task in which the subject must verify if an instance 
(“AB” or “BA”) is concordant with a statement 
(e.g., “A follows B”) by pressing the “Yes” or “No” 
button as quickly as possible. The stimuli vary on 
the following dimensions; the verb (“precedes vs 
follows”), active -passive, positive -negative, 
whether the first letter is “A” or ‘73” and whether 
the statement is true or false. The average response 
latency on the active, passive, positive and negative 
condition is used as well as the number of correct 
answers in each condition. 
Reaction speed 
Simple reaction time: Subjects are required to press 
a button as quickly as possible if a large square 
appears on the screen. Reaction times are used for 
analysis. 
Switching attention (SA): This is a test measuring 
the ability to switch rapidly between different types 
of response requirements indicated by two-choice 
visual discriminations. There are three different 
testing conditions. In the first condition (“side”), 
the subject must respond to each of a series of 
rectangles presented in succession on the monitor. 
The rectangle appears on either the left or the right 
side of the screen. The subject has to press the button 
on the corresponding side. In the second condition 
(“direction”), an arrow, pointing to either the left or 
the right, is presented in the middle of the screen. The 
corresponding button has to be pressed as swiftly as 
possible. The third condition (“switching”), the 
words “side” or “direction”, serving as a response 
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instruction, appear directly preceding each reaction 
stimulus. These stimuli are arrows pointing to either 
the left or the right and are presented either on the left 
or on the right side of the screen. Measures are mean 
response latencies in each condition. 
Motor jimctioning 
Finger taps: This is a test of motor speed and 
accuracy, requiring key tapping with the index 
finger of the preferred, nonpreferred and both 
hands in alternation. The measure is the number 
of taps generated within a 30 s interval in these 
three conditions. 
Hand -eye coordination (HEC): This test of dexter- 
ity and visuomotor coordination is executed with 
the dominant hand. A series of three sawtooth and 
four sinuses are presented on the monitor. The 
subject controls the vertical location of a cursor, the 
horizontal movement of which is preprogrammed, 
in order to keep it synchronous with the pattern on 
the screen. The measure is log root square error of 
the two best trials. 
Selective attention 
Continuous perjimmnce (CP) with pictures: Visual 
attention is measured by this task in which reaction 
speed is recorded in response to a target stimulus 
(cat) semi-randomly embedded in a series of images 
of animal silhouettes. Stimuli are presented without 
intervals. The measures are mean response latency 
and number of false-positive and nonresponses. 
Continuous pef$ormance (CP) with letters: This test 
measures sustained visual attention. Reaction speed 
is recorded in response to a target letter semi- 
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randomly embedded in a series of five single letters, 
sequentially presented. The measures are mean 
response latency and the number of false-positive 
and nonresponses. 
C&r wmd: This is an equivalent of the Stroop 
test. The words “red”, “blue”, “green”, and 
“yellow” are presented for 1500 ms one at a time 
in the center of the screen with an interval of 
700 ms. In addition, the words are printed in one of 
these four colors. Only when color and word are 
congruent are the subjects required to press a 
button. The measures are number of false-positive 
and nonresponses and the response latencies for 
correct responses. 
Digit encoding 
Serial digits: A sequence of eight digits is briefly 
presented. A maximum of eight trials is presented 
repeatedly until the subject recalls the whole 
sequence. The learning criterion is two successive 
correct trials. The measure is a weighted score 
reflecting the number of errors on each trial. 
Symbol digit substitution (SYMDG): The subject is 
required to enter the digit associated with each 
symbol from the keyboard. The pairing of symbols 
and digits changes randomly on each trial. Errors 
must be corrected before proceeding. The measure 
is the average mean latency per digit for the two 
fastest trials. 
HorizontaZ addition: This test measures not only 
basic arithmetic ability but also aspects of mental _ 
manipulation. A row of three one-digit numbers is 
presented and the subject must enter each two-digit 
answer from left to right. The measure is the 
response latency and number of correct responses. 
Visual digit span 
Visual digit span: A sequence of digits is 
presented one at a time, after which the subject 
is required to enter the sequence on the computer 
keyboard. Increasingly longer digit spans are 
presented until two errors are made at a span 
length. After these two errors a second condition is 
initiated in which the backward digit span is 
established. At each span length, the span is 
increased by one if the subject answers correctly. 
If the subject responds incorrectly, a second trial 
with a different sequence but identical span length 
is administered. Testing ends if two successive 
trials are incorrect. The measure is the maximum 
correct span length. 
Pattern perception 
Pattern comparison: A pattern comparison task in 
which three arrays consisting of 100 black and 
white blocks (10 x 10) are presented. Two of the 
arrays are identical and the third contains four 
pseudorandomly chosen blocks that differ in color. 
The subject is asked to choose the pattern that 
differs from the other two. The measures are mean 
response latency on correct trials and number of 
correct responses. 
Pattern memory: A single array consisting of 100 
black and white blocks (10 x 10) is presented for 
4000 ms. After a 3 s interval, three arrays are 
presented simultaneously. On each of the 25 trials 
the subject has to choose which one matches the 
original array. The nontargets are different from the 
target with respect to five blocks within the array. 
The measure is the mean response latency on 
correct trials and number of correct responses. 
